WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Colby Cosh: Did Ozempic kill its Canadian patent?

Generic versions of the weight loss drug are about to hit the market

Raccontata dafinancialpost.comnationalpost.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
nationalpost.comStai leggendo1 mesi fa

Colby Cosh: Did Ozempic kill its Canadian patent?

Generic versions of the weight loss drug are about to hit the market

originale
financialpost.com1 mesi fa

Canadians can now get digital prescriptions for 'generic Ozempic'

Hims & Hers Health announced the availability of generic semaglutide, allowing Canadians access to digital prescriptions. Read more.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 21 maggio 2026·financialpost.com

    Canadians can now get digital prescriptions for 'generic Ozempic'

    Hims & Hers Health announced the availability of generic semaglutide, allowing Canadians access to digital prescriptions. Read more.

  2. venerdì 22 maggio 2026·nationalpost.com

    Colby Cosh: Did Ozempic kill its Canadian patent?

    Generic versions of the weight loss drug are about to hit the market

  3. venerdì 22 maggio 2026·nationalpost.com

    Generic Ozempic landing soon on Canadian pharmacy shelves

    The Canadian Medical Association says the arrival of generics could “mean an increase in the number of plans" that will cover these drugs.